Treatment options for localized prostate cancer - Abstract

In the United States, more than 90 percent of prostate cancers are detected by serum prostate-specific antigen testing.

 

Most patients are found to have localized prostate cancer, and most of these patients undergo surgery or radiotherapy. However, many patients have low-risk cancer and can follow an active surveillance protocol instead of undergoing invasive treatments. Active surveillance is a new concept in which low-risk patients are closely followed and proceed to intervention only if their cancer progresses. Clinical guidelines can help in selecting between treatment or active surveillance based on the cancer's stage and grade, the patient's prostate-specific antigen level, and the comorbidity-adjusted life expectancy. Radical prostatectomy or external beam radiation therapy is recommended for higher-risk patients. These treatments are almost equivalent in effectiveness, but have different adverse effect profiles. Brachytherapy is an option for low- and moderate-risk patients. Evidence is insufficient to determine whether laparoscopic or robotic surgery or cryotherapy is superior to open radical prostatectomy.

Written by:
Mohan R, Schellhammer PF.   Are you the author?

Reference: Am Fam Physician. 2011 Aug 15;84(4):413-20.

PubMed Abstract
PMID: 21842788

UroToday.com Prostate Cancer Section

 

 

email news signup